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优化实验。优化条件为采用丙酮作为溶剂，投料比为 1：1，超声功率为 200 W，
超声时间为 3 s，间隙 3 s，冰浴条件下反复 150 次。根据优化实验结果，对优化
条件下制备的羟基喜树碱纳米针的粒径、Zeta 电位、载药量、包封率、形貌、HCPT
的存在状态进行分析。结果表明：羟基喜树碱纳米针为两端尖，中部略宽，长 5 













摘  要 
II 
 
其平均粒径为 356.7 nm，多分散系数为 0.063，zeta 电位为-10.9 mV。羟基喜树
碱纳米针的载药量为 55.84%，包封率为 90.32%，且缓释效果良好，在 pH=7.4的
缓冲溶液中，能够于 400 h内缓慢的释放药物。 
(2) 体外细胞摄取及细胞毒性实验。体外细胞摄取实验表明，不管是三种癌
细胞（HeLa 细胞，MG-63 细胞和 MCF-7 细胞）还是正常细胞（MC3T3-E1 细
胞），对针状纳米粒子的细胞摄取的速率最快，数量也最多，而对相同尺寸，相





况一样，都是针状纳米粒子 > 棒状纳米粒子 > 球状纳米粒子。 







中部略宽的针状结构，但其长度约 1 µm，宽约 100 nm，粒径分布较为均一，分
散性较好，动态光散射分析其平均粒径为 102.6 nm，多分散系数为 0.049，zeta电
位为-19.3 mV，其羟基喜树碱的载药量为 62.56%，包封率为 92.43%，甲氨喋呤
的载药量为 2.03%。该双载药纳米针缓释效果良好，在 pH=7.4 的缓冲溶液中，











































The cellular uptake of the particles is a paramount factor to the therapeutic effect 
of drug delivery systems. To facilitate the cellular uptake of the nanoparticles, the 
concentration of the research has been focused on controlling the size of the particles. 
Although the effect of size on the cellular uptake into nonphagocytic cells is still far 
from being fully understood, it is always accepted that the size of nanoparticles might 
play the most important role in cellular uptake. It was once believed that the upper limit 
of the size of the nanoparticles that could be internalized into nonphagocytic cells via 
nonspecific endocytosis was 150 nm. And the uptake of nanoparticles will increase with 
the particle size of less than 50 nm, and decrease for larger nanoparticles. We notice 
that all these studies were performed based on spherical nanoparticles, and neglected 
the influence of the particle shape. This was most likely due to the lack of easy-to-use 
methods available to control the particle shape. Since the last decade, the non-spherical 
particle shape have been attracting more and more attentions for their potential use in 
drug delivery system, due to the great progress made in attaining diversely shaped 
particles. Although the effect of particle shape on drug delivery has not been thoroughly 
examined, there have been already evidences showing that many properties of the 
particles are particle shape dependent.  
10-hydroxycamptothecin (HCPT) is a promising broad-spectrum antitumor agent 
which targets nuclear enzyme topoisomerase I and has achieved remarkable success in 
the early clinical trials. Nevertheless, the clinical application of HCPT was now largely 
hampered because of the suboptimal pharmaceutical properties, such as poor solubility, 
poor stability, short half-life and so on. This would lead to a quite low therapeutic 
efficiency and a number of side effects to normal tissues such as thrombocytopenia, 
neutropenia, and diarrhea. Therefore, finding a novel formulation suitable for the 
delivery of HCPT is of great significance in fully unleashing the potential of HCPT. 
What’s more, the natural HCPT is in the form of rod-shaped crystals, which means that 
















Hence, in this study, we will fabricate a new kind of high-aspect-ratio, pointed-
end and HCPT-loaded nanoneedles with sustained drug release. To implement this idea, 
the anti-solvent co-precipitation of PEG-b-PLGA and HCPT will be employed under 
sonication and ice-bath to control the nucleation of the nanoneedles with 
nanocrystalline HCPT. In this fabrication, the core of HCPT will be wrapped with PEG-
b-PLGA as steric stabilizers. In vitro studies will be then systematically carried out to 
examine the effect of the HCPT-loaded nanoneedles against cancer cells and normal 
cells compared with the rod-shaped particles and the nanospheres. 
The contents are summarized as follows: 
(1) Preparation and characterization of HCPT-loaded nanoneedles. In this 
work, our aim was to obtain the needle-shaped nanoparticles. For this purpose, 
influences of different initial conditions, including the ratio of HCPT to PEG-b-PLGA, 
and the power of sonication, were investigated to abtain the optimal formulation 
condition. The results were as follows: the organic solvents was acetone; the ratio of 
HCPT to PEG-b-PLGA was 1:1; the power of the sonication was 200 W; the sonication 
time was sonication for 3 s, interval for 3 s and repeated for 150 times in ice-bath. The 
obtained nanoneedles were characterized by scanning electron microscopy 
(SEM)/transmission electron microscopy (TEM), dynamic light scattering (DLS), and 
X-ray diffraction (XRD). Based on these experimental results, it was proposed that 
HCPT-loaded nanoneedles exhibited well dispersed, fairly uniform size and a pointed-
end, needle-like shape with a length of about 5 µm and a width of about 400 nm. The 
DLS analysis illustrated that the size of the nanoneedles was 356.7 nm, the zeta 
potential was -10.9 mV and the PDI was 0.063. The drug-loading and entrapment 
efficiency respectively of nanoneedles were 55.84% and 90.32%. Their release 
behavior in vitro showed that the nanoneedles could slowly release the drug in 400 h in 
PBS (pH=7.4). 
(2) In vitro cellular uptake and cytotoxicity assay of HCPT-loaded 
nanoneedles. The cellular uptake test was carried out by using three types of cancer 
cells (HeLa cells, MG-63 cells, and MCF-7 cells) and one type of normal cells 
















nanospheres with a much smaller size were used as control. Interestingly, the results of 
these tests were all the same: the cellular uptake of the nanoneedles was a little stronger 
than that of the nanorods. And the cellular uptake of the nanospheres was the least in 
the three types of nanoparticles. We discussed the possible reasons for the phenomenon. 
We define the angle Φ to roughly illustrate the role of shape in nonphagocytosis uptake. 
Two vectors (?̅? and ?̅?) were used to show the flow directions of the cell membranes. 
Φ is the angle between ?̅? and ?̅?. The cell membranes flow easly, when the Φ is small. 
And the cytotoxicity test indicated that the order of the killing ability was NDs > NRs > 
NSs, which was in according with the results the cellular uptake test. 
(3) The synthesis of the PEG-b-PLGA-MTX conjugate. We conjugate MTX to 
PEG-b-PLGA via an ester bond. The FTIR spectrum illustrated that the ester bond was 
exist and the conjugate PEG-b-PLGA-MTX was successfully synthesized. We 
calculated the percentage of the MTX in the conjugation via ultraviolet spectroscopy. 
(4) Preparation and characterization of dual drug loaded nanoneedles. We 
improved the sonication assisted anti-solvent recrystallization method by using the 
solvent of acetone-ethanol mixtures and smaller dosages. Both MTX and HCPT loaded 
nanoneedles with a smaller size were successfully synthesized via the optimized 
method. The SEM images illustrated that the dual drug loaded nanoneedles exhibited 
well dispersed, fairly uniform size and a pointed-end, needle-like shape with a length 
of about 1 µm and a width of about 100 nm. The DLS analysis illustrated that the size 
of the nanoneedles was 102.6 nm, the zeta potential was -19.3 mV and the PDI was 
0.049. The drug-loading and entrapment efficiency of HCPT in the dual drug loaded 
nanoneedles were 62.56% and 92.43%, respectively. And the drug-loading of MTX was 
2.03%. Their release behavior in vitro showed that the dual drug loaded nanoneedles 
could slowly release both of the drug in 400 h in PBS (pH=7.4). 
(5) The in vitro and in vivo studies. The in vitro and in vivo studies were then 
systematically carried out to examine the effect of the dual drug loaded nanoneedles 
against cancer cells. The cellular uptake test was carried out with HeLa cells and used 
HCPT-loaded nanoneedles with the same size as control. The cellular uptake of the dual 
















nanoneedles. And this enhancement was disappeared, when the folate receptors on the 
cell membranes were blocked with folate. This stated that the enhanced cellular uptake 
of the dual drug loaded nanoneedles was caused by the affinity between MTX and the 
folate receptors in target cells, which would lead to the receptor-mediated endocytosis. 
The cytotoxicity test indicated that the killing ability of the dual drug loaded 
nanoneedles was stronger than that of the individual drugs, the mixture of individual 
drugs, or the mixture of MTX and the HCPT-loaded nanoneedles. This illustrated the 
good synergistic effect and targeting property of the dual drug loaded nanoneedles. The 
in-vivo fluorescence test also stated the good targeting property of the dual drug loaded 
nanoneedles. The in-vivo antitumor experiment showed the excellent anticancer 
property and the slight side effect. 
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